| NCT03939767 |
Assessment of Proactive Treatments in Patients With Wet Age-related Macular Degeneration (wAMD) Which Have Never Undergone Treatment of This Particular Disease |
https://ClinicalTrials.gov/show/NCT03939767 |
Recruiting |
Bayer |
2023-05-15 |
| NCT03714308 |
Aflibercept Injection Into the Vitreous Body of the Eye: Study to Learn More About Patient Relevant Outcomes, Real World Treatment Patterns and How Well the Treatment Works for Patients Suffering From Abnormal Growth of New Blood Vessels Under the Retina. |
https://ClinicalTrials.gov/show/NCT03714308 |
Recruiting |
Bayer |
2022-12-31 |
| NCT03688243 |
Non Exudative AMD Imaged With SS-OCT |
https://ClinicalTrials.gov/show/NCT03688243 |
Recruiting |
Boston Image Reading Center |
2022-01-31 |
| NCT03470103 |
A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America |
https://ClinicalTrials.gov/show/NCT03470103 |
Active, not recruiting |
Bayer |
2020-09-30 |
| NCT03382587 |
Observational Study to Assess Intravitreal Aflibercept Injections Used in a “Treat and Extend” Regimen in Treatment-naïve Wet Age-related Macular Degeneration Patients |
https://ClinicalTrials.gov/show/NCT03382587 |
Completed |
Bayer |
2018-11-09 |
| NCT03374020 |
Retinal Imaging Using NOTAL-OCT |
https://ClinicalTrials.gov/show/NCT03374020 |
Active, not recruiting |
Notal Vision Ltd |
2019-12-30 |
| NCT03372746 |
Generation of Induced Pluripotent Stem (iPS) Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT03372746 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-03-21 |
| NCT03823092 |
Polarization Perception in Health and Disease. Testing a New Sight Test |
https://ClinicalTrials.gov/show/NCT03823092 |
Recruiting |
South Warwickshire NHS Foundation Trust |
2019-04-30 |
| NCT03326401 |
The Potential Role of Dietary Antioxidant Capacity on Age-Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT03326401 |
Completed |
Hacettepe University |
2015-10-01 |
| NCT03324542 |
Real World Outcomes of Intravitreal Anti-vascular Endothelial Growth Factors for Neovascular Age Related Macular Degeneration in Taiwan |
https://ClinicalTrials.gov/show/NCT03324542 |
Completed |
Changhua Christian Hospital |
2017-10-13 |
| NCT03322930 |
Rod Sensitivity in Age-related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP) |
https://ClinicalTrials.gov/show/NCT03322930 |
Completed |
Retina Foundation of the Southwest |
2019-03-01 |
| NCT03318549 |
Evaluation of Visual and Task Performance |
https://ClinicalTrials.gov/show/NCT03318549 |
Enrolling by invitation |
Duke University |
2022-12-31 |
| NCT03313401 |
Effect of Aflibercept on Human Corneal Endothelial Cells in Neovascular Age-Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT03313401 |
Completed |
Ulucanlar Eye Training and Research Hospital |
2017-05-31 |
| NCT03278262 |
The Impact of Baseline Visual Acuity on the Treatment Outcomes in Patients Treated With AflIbercept in Real-life Clinical Setting |
https://ClinicalTrials.gov/show/NCT03278262 |
Completed |
Bayer |
2017-12-31 |
| NCT03275753 |
Visual Function Tests in Age-related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT03275753 |
Recruiting |
ORA, Inc. |
2019-12-31 |
| NCT03242083 |
Evaluate the Quality of Life of Patients With AMD |
https://ClinicalTrials.gov/show/NCT03242083 |
Completed |
Centre Hospitalier Universitaire Dijon |
2019-12-03 |
| NCT03225131 |
Dark Adaptation in Participants With Age-Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT03225131 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2029-12-31 |
| NCT03222362 |
Pars Plana Vitrecromy in Patients Aged 85 Years and Above |
https://ClinicalTrials.gov/show/NCT03222362 |
Completed |
Tel Aviv Medical Center |
2013-12-31 |
| NCT03166202 |
Age-Related Macular Degeneration, Scotopic Dysfunction, and Driving Performance in a Simulator |
https://ClinicalTrials.gov/show/NCT03166202 |
Completed |
University of Alabama at Birmingham |
2019-03-05 |
| NCT03102138 |
Retinal Pigment Epithelium Safety Study For Patients In B4711001 |
https://ClinicalTrials.gov/show/NCT03102138 |
Active, not recruiting |
Moorfields Eye Hospital NHS Foundation Trust |
2020-10-04 |
| NCT03092492 |
AMD Ryan Initiative Study (ARIS) |
https://ClinicalTrials.gov/show/NCT03092492 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2023-10-25 |
| NCT03079570 |
Flicker Fusion Thresholds Between Young and Old Subjects at Various Luminance Levels |
https://ClinicalTrials.gov/show/NCT03079570 |
Completed |
ORA, Inc. |
2016-09-08 |
| NCT03076697 |
Smartphone Screening for Eye Diseases |
https://ClinicalTrials.gov/show/NCT03076697 |
Enrolling by invitation |
University of Michigan |
2023-06-30 |
| NCT03035461 |
Patient’s Feelings After Receiving a Diagnosis of Age-related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT03035461 |
Completed |
Centre Hospitalier Intercommunal Creteil |
2018-02-01 |
| NCT03030729 |
Macular Thickness Measurements Using Retinal-thickness OCT |
https://ClinicalTrials.gov/show/NCT03030729 |
Completed |
Notal Vision Ltd |
2018-01-14 |
| NCT02941991 |
A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt’s Macular Dystrophy (SMD) |
https://ClinicalTrials.gov/show/NCT02941991 |
Completed |
Astellas Pharma Inc |
2019-10-02 |
| NCT02941263 |
Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT02941263 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2022-12-31 |
| NCT02875704 |
Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT02875704 |
Recruiting |
Johns Hopkins University |
2021-05-31 |
| NCT02748824 |
Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal |
https://ClinicalTrials.gov/show/NCT02748824 |
Completed |
Association for Innovation and Biomedical Research on Light and Image |
2017-09-18 |
| NCT02669953 |
Aflibercept in Recurrent or Persistent CNV |
https://ClinicalTrials.gov/show/NCT02669953 |
Recruiting |
Medical University of Vienna |
2020-12-31 |
| NCT02615496 |
Evaluation of Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept |
https://ClinicalTrials.gov/show/NCT02615496 |
Completed |
Bayer |
2016-09-30 |
| NCT02588378 |
The Role of Inflammation in AMD and Related Disorders |
https://ClinicalTrials.gov/show/NCT02588378 |
Recruiting |
St. Michael’s Hospital, Toronto |
2020-05-31 |
| NCT02585401 |
Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada |
https://ClinicalTrials.gov/show/NCT02585401 |
Completed |
Bayer |
2016-03-31 |
| NCT02422160 |
Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT02422160 |
Recruiting |
Stanford University |
2021-12-31 |
| NCT02567604 |
Development of Core Outcomes for Age-related Macular Degeneration (AMD) Interventions- Caregivers’ Perspective |
https://ClinicalTrials.gov/show/NCT02567604 |
Completed |
Queen’s University, Belfast |
2018-09-30 |
| NCT01496625 |
National Eye Institute Biorepository for Retinal Diseases |
https://ClinicalTrials.gov/show/NCT01496625 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02550002 |
Comparison of Treatment rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen |
https://ClinicalTrials.gov/show/NCT02550002 |
Active, not recruiting |
University Hospital Inselspital, Berne |
2022-03-31 |
| NCT02541084 |
Caregiver Burden of Wet Age-related Macular Degeneration (wAMD) in Japan |
https://ClinicalTrials.gov/show/NCT02541084 |
Completed |
Bayer |
2016-03-30 |
| NCT02540369 |
To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada. |
https://ClinicalTrials.gov/show/NCT02540369 |
Completed |
Bayer |
2017-09-25 |
| NCT02528058 |
Ultrastructure Analysis of Excised Internal Limiting Membrane in Eyes of Highly Myopia With Myopic Traction Maculopathy |
https://ClinicalTrials.gov/show/NCT02528058 |
Completed |
Kyorin University |
2014-07-31 |
| NCT02528045 |
Vitrectomy and Scleral Shortening for Macular Hole Retinal Detachment or Myopic Traction Maculopathy |
https://ClinicalTrials.gov/show/NCT02528045 |
Completed |
Kyorin University |
2014-07-31 |
| NCT02028351 |
Vision Measured by the Vimetrics CVA Compared With Chart Testing Under Similar Luminance and Contrast Conditions |
https://ClinicalTrials.gov/show/NCT02028351 |
Completed |
Sinclair Technologies, LLC |
2009-03-31 |
| NCT02452840 |
Photodynamic Therapy for PDA in NV AMD |
https://ClinicalTrials.gov/show/NCT02452840 |
Recruiting |
Duke University |
2022-05-31 |
| NCT02445612 |
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients |
https://ClinicalTrials.gov/show/NCT02445612 |
Completed |
Astellas Pharma Inc |
2019-06-21 |
| NCT02445313 |
Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device |
https://ClinicalTrials.gov/show/NCT02445313 |
Completed |
Doheny Image Reading Center |
2019-02-12 |
| NCT02438111 |
The Role of the Gut Metagenome on the Development of Age Related Macular Degeneration (AMD) |
https://ClinicalTrials.gov/show/NCT02438111 |
Recruiting |
University Hospital Inselspital, Berne |
2020-11-30 |
| NCT02420132 |
Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®) |
https://ClinicalTrials.gov/show/NCT02420132 |
Completed |
Hoffmann-La Roche |
2016-08-25 |
| NCT02410122 |
The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy |
https://ClinicalTrials.gov/show/NCT02410122 |
Completed |
Johns Hopkins University |
2018-03-31 |
| NCT02367365 |
Neovascular Morphology and Persistent Disease Activity Among Patients With NV AMD |
https://ClinicalTrials.gov/show/NCT02367365 |
Completed |
Duke University |
2017-12-31 |
| NCT02332343 |
Sparing of the Fovea in Geographic Atrophy Progression |
https://ClinicalTrials.gov/show/NCT02332343 |
Completed |
University Hospital, Bonn |
2017-01-31 |
| NCT02321241 |
Real Life of Aflibercept in France in Patients Refractory to Ranibizumab: Observational Study in Wet AMD |
https://ClinicalTrials.gov/show/NCT02321241 |
Completed |
Bayer |
2017-01-18 |
| NCT02313259 |
The Impact of Ocular Diseases on Driving: a Prospective Study |
https://ClinicalTrials.gov/show/NCT02313259 |
Completed |
CHU de Quebec-Universite Laval |
2015-02-23 |
| NCT02308215 |
Retinal Therapy Guided by 3D OCT Image Analysis |
https://ClinicalTrials.gov/show/NCT02308215 |
Completed |
University of Iowa |
2018-07-05 |
| NCT02291887 |
Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept |
https://ClinicalTrials.gov/show/NCT02291887 |
Completed |
Associated Retinal Consultants, Michigan |
2015-07-01 |
| NCT02289924 |
Aflibercept (Eylea) in roUtine Clinical Practice in patientS With Wet Age-related Macular Degeneration in Italy |
https://ClinicalTrials.gov/show/NCT02289924 |
Completed |
Bayer |
2019-03-28 |
| NCT02287298 |
Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment |
https://ClinicalTrials.gov/show/NCT02287298 |
Completed |
The Retina Center of St. Louis County, PC |
2015-12-31 |
| NCT02279537 |
Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMD |
https://ClinicalTrials.gov/show/NCT02279537 |
Completed |
Bayer |
2019-04-17 |
| NCT02253030 |
OCT Angiography in Wet AMD |
https://ClinicalTrials.gov/show/NCT02253030 |
Recruiting |
Oregon Health and Science University |
2022-12-31 |
| NCT02225119 |
The Focal Electro-Oculogram in Macular Disease |
https://ClinicalTrials.gov/show/NCT02225119 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-05-07 |
| NCT02218177 |
Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMD |
https://ClinicalTrials.gov/show/NCT02218177 |
Completed |
University Health Network, Toronto |
2016-08-31 |
| NCT02173496 |
Colour Contrast Sensitivity for the Early Detection of Wet Age-related Macular Degereration (CEDAR) |
https://ClinicalTrials.gov/show/NCT02173496 |
Completed |
Aston University |
2017-05-31 |
| NCT02162953 |
Stem Cell Models of Best Disease and Other Retinal Degenerative Diseases. |
https://ClinicalTrials.gov/show/NCT02162953 |
Active, not recruiting |
Mayo Clinic |
2021-12-31 |
| NCT02126423 |
Resistance to Antibiotics in Patients Receiving Eye Injections |
https://ClinicalTrials.gov/show/NCT02126423 |
Completed |
Prism Vision Group |
2014-09-30 |
| NCT01318941 |
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting |
https://ClinicalTrials.gov/show/NCT01318941 |
Completed |
Novartis |
2016-04-30 |
| NCT02090751 |
Development of a Device to Measure Dark Adaptation |
https://ClinicalTrials.gov/show/NCT02090751 |
Completed |
University of Manchester |
2015-02-28 |
| NCT01310686 |
Genetics Study of Wet Age-Related Macular Degeneration (AMD) Non-Responders to Vascular Endothelial Growth Factor (VEGF) Therapy |
https://ClinicalTrials.gov/show/NCT01310686 |
Active, not recruiting |
West Coast Retina Medical Group, Inc. |
2019-06-30 |
| NCT01298674 |
Epidemiological Study of the Prevalence of Age-Related Macular Degeneration in Portugal |
https://ClinicalTrials.gov/show/NCT01298674 |
Completed |
Association for Innovation and Biomedical Research on Light and Image |
2013-10-31 |
| NCT01272076 |
Cirrus HD-OCT Measurement of Area of Increased Light Penetration Under the Retinal Pigment Epithelium (RPE) |
https://ClinicalTrials.gov/show/NCT01272076 |
Completed |
Carl Zeiss Meditec, Inc. |
2011-02-28 |
| NCT01272063 |
Measurement and Analysis of Macular Retinal Pigment Epithelium (RPE) Elevations With Cirrus HD-OCT vs. Color Fundus Photography |
https://ClinicalTrials.gov/show/NCT01272063 |
Completed |
Carl Zeiss Meditec, Inc. |
2011-02-28 |
| NCT02055612 |
Mobile Clinic - a Cross-sectional Epidemiological Survey |
https://ClinicalTrials.gov/show/NCT02055612 |
Completed |
Novartis |
2013-05-31 |
| NCT02051998 |
Directional Spread in Geographic Atrophy |
https://ClinicalTrials.gov/show/NCT02051998 |
Completed |
University Hospital, Bonn |
2019-11-30 |
| NCT01996215 |
Brain Connectivity in Age-Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT01996215 |
Completed |
Duke University |
2018-06-30 |
| NCT01977846 |
A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies |
https://ClinicalTrials.gov/show/NCT01977846 |
Completed |
Foundation Fighting Blindness |
2017-02-28 |
| NCT01942213 |
Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients. |
https://ClinicalTrials.gov/show/NCT01942213 |
Completed |
Prism Vision Group |
2016-04-30 |
| NCT01915238 |
Study of the Effects of Supplements on Eye Disease in Participants From the Age-Related Eye Disease Study |
https://ClinicalTrials.gov/show/NCT01915238 |
Completed |
National Institutes of Health Clinical Center (CC) |
2014-06-20 |
| NCT01914380 |
Investigating the Effectiveness of Eylea in Patients With Wet Age-related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT01914380 |
Completed |
Bayer |
2017-03-31 |
| NCT01880788 |
Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD |
https://ClinicalTrials.gov/show/NCT01880788 |
Completed |
Sequenom, Inc. |
2015-03-31 |
| NCT01876147 |
Visual and Functional Assessment in Low Vision Patients |
https://ClinicalTrials.gov/show/NCT01876147 |
Completed |
University of Oxford |
2016-03-31 |
| NCT01846351 |
Intravitreal Anti-VEGF in Exudative AMD With Epiretinal Membranes |
https://ClinicalTrials.gov/show/NCT01846351 |
Completed |
New England Retina Associates |
2010-02-28 |
| NCT01822873 |
Study on Visual Function Impairments in Dry Age-related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT01822873 |
Completed |
Duke University |
2018-07-31 |
| NCT01783925 |
Eylea Post Marketing Surveillance(PMS) |
https://ClinicalTrials.gov/show/NCT01783925 |
Completed |
Bayer |
2018-12-31 |
| NCT01778491 |
AMD Phenotype and Genotype Study |
https://ClinicalTrials.gov/show/NCT01778491 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-09-29 |
| NCT01771081 |
Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy |
https://ClinicalTrials.gov/show/NCT01771081 |
Completed |
Bayer |
2015-01-31 |
| NCT01756261 |
EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan |
https://ClinicalTrials.gov/show/NCT01756261 |
Completed |
Bayer |
2016-07-20 |
| NCT01756248 |
EYLEA Age-Related Macular Degeneration (AMD) Post-marketing Surveillance in Japan |
https://ClinicalTrials.gov/show/NCT01756248 |
Completed |
Bayer |
2018-12-31 |
| NCT01715870 |
Life Style and Food Habits Questionnaire in the Portuguese Population Aged 55 or More |
https://ClinicalTrials.gov/show/NCT01715870 |
Completed |
Association for Innovation and Biomedical Research on Light and Image |
2014-04-30 |
| NCT01712841 |
Non-exudative Age-related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT01712841 |
Completed |
Oregon Health and Science University |
2018-01-18 |
| NCT01712035 |
Neovascular Age-related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT01712035 |
Completed |
Oregon Health and Science University |
2017-12-05 |
| NCT01692938 |
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO |
https://ClinicalTrials.gov/show/NCT01692938 |
Completed |
Optos, PLC |
2012-11-30 |
| NCT01682382 |
Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV) |
https://ClinicalTrials.gov/show/NCT01682382 |
Completed |
Sequenom, Inc. |
2013-08-31 |
| NCT01670643 |
Reading Performance With a Video Magnifier |
https://ClinicalTrials.gov/show/NCT01670643 |
Completed |
Massachusetts Eye and Ear Infirmary |
2010-04-30 |
| NCT03349801 |
Development of Novel Clinical Endpoints in Intermediate AMD |
https://ClinicalTrials.gov/show/NCT03349801 |
Recruiting |
University Hospital, Bonn |
2022-02-28 |
| NCT01666821 |
A Population-based Study of Macular Choroidal Neovascularization in a Chinese Population |
https://ClinicalTrials.gov/show/NCT01666821 |
Completed |
Shanghai University of Traditional Chinese Medicine |
2008-09-30 |
| NCT01650948 |
Genetic Load and Phenotype in Aggressive AMD |
https://ClinicalTrials.gov/show/NCT01650948 |
Completed |
Sequenom, Inc. |
2013-12-31 |
| NCT01644513 |
Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients |
https://ClinicalTrials.gov/show/NCT01644513 |
Completed |
Sequenom, Inc. |
2012-12-31 |
| NCT01581606 |
Evaluation of TeleOphthalmology in AMD-TeleMedicine Solutions to Improve Patient Access and Quality of Vision Outcomes |
https://ClinicalTrials.gov/show/NCT01581606 |
Completed |
Lawson Health Research Institute |
2014-04-04 |
| NCT01553474 |
Blood and Saliva Sample Collection for AREDS 2 |
https://ClinicalTrials.gov/show/NCT01553474 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01527435 |
Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD) |
https://ClinicalTrials.gov/show/NCT01527435 |
Completed |
The Retina Center of St. Louis County, PC |
2015-12-31 |
| NCT01526070 |
Study of Bimonthly VEGF Trap-Eye Compared to As-needed Administration or Other Therapy for Exudative Age-Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT01526070 |
Completed |
Stanford University |
2014-07-31 |
| NCT01464710 |
Genetic Assessment of Early to Late Macular Degeneration Study |
https://ClinicalTrials.gov/show/NCT01464710 |
Completed |
University of California, San Diego |
2015-01-31 |
| NCT01448538 |
Non-Persistence/Non-Adherence (NP/NA) in Wet Age-related Macular Degeneration (wAMD) Patients in Germany |
https://ClinicalTrials.gov/show/NCT01448538 |
Completed |
Bayer |
2013-12-31 |
| NCT01447043 |
Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA) |
https://ClinicalTrials.gov/show/NCT01447043 |
Completed |
Bayer |
2011-08-31 |
| NCT01334294 |
Home Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT01334294 |
Completed |
Notal Vision Ltd |
2013-12-31 |
| NCT01330797 |
The Effect of Ranibizumab on Eye Lens Opacity in Cases With Age-Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT01330797 |
Completed |
Uludag University |
2010-10-31 |
| NCT00594672 |
Age-Related Eye Disease Study (AREDS) Follow-Up |
https://ClinicalTrials.gov/show/NCT00594672 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT04395859 |
Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents |
https://ClinicalTrials.gov/show/NCT04395859 |
Recruiting |
Fondation Ophtalmologique Adolphe de Rothschild |
2021-12-31 |
| NCT04377295 |
Evaluation of Retinal and Vascular Features in Radiation Maculopathy After Intravitreal Injections of Ranibizumab |
https://ClinicalTrials.gov/show/NCT04377295 |
Completed |
Federico II University |
2019-10-01 |
| NCT04349254 |
Observational Study of Vision Improvement in Late Stage Dry AMD Patients |
https://ClinicalTrials.gov/show/NCT04349254 |
Recruiting |
Optimal Acuity Corporation |
2020-12-31 |
| NCT04281732 |
Visual Performance Measures in a Virtual Reality Environment for Assessing Clinical Trial Outcomes in Those With Severely Reduced Vision |
https://ClinicalTrials.gov/show/NCT04281732 |
Recruiting |
Queen’s University, Belfast |
2020-09-30 |
| NCT04278300 |
Study of the Discriminating Power of a Blood Biomarker for Omega-3 Polyunsaturated Fatty Acid Content of the Retina for Age-related Macular Degeneration (AMD) |
https://ClinicalTrials.gov/show/NCT04278300 |
Recruiting |
Centre Hospitalier Universitaire Dijon |
2022-02-28 |
| NCT04270604 |
Biological Sample Collection for Research and Biobanking |
https://ClinicalTrials.gov/show/NCT04270604 |
Recruiting |
The New York Stem Cell Foundation |
2030-01-31 |
| NCT04269304 |
Deciphering AMD by Deep Phenotyping and Machine Learning- Prospective Study - PINNACLE |
https://ClinicalTrials.gov/show/NCT04269304 |
Recruiting |
University of Southampton |
2023-12-31 |
| NCT04196049 |
Removal of Massive Subretinal Organized Blood Clot With Fragmatome |
https://ClinicalTrials.gov/show/NCT04196049 |
Completed |
Changhua Christian Hospital |
2019-10-31 |
| NCT04187157 |
Association Between Light Spectrum and Survival After Cataract Surgery |
https://ClinicalTrials.gov/show/NCT04187157 |
Completed |
University of Pittsburgh |
2019-04-30 |
| NCT04169802 |
Study Evaluating Retinal Health Monitoring System Visual Acuity Module. |
https://ClinicalTrials.gov/show/NCT04169802 |
Completed |
Kubota Vision Inc. |
2020-04-15 |
| NCT04138420 |
Evaluation of Retinal and Vascular Features in Macular Degeneration After Intravitreal Injections of Bevacizumab |
https://ClinicalTrials.gov/show/NCT04138420 |
Completed |
Federico II University |
2017-10-25 |
| NCT04112667 |
Functionally Validated Structural Endpoints for Early AMD |
https://ClinicalTrials.gov/show/NCT04112667 |
Recruiting |
University of Alabama at Birmingham |
2024-02-29 |
| NCT04101604 |
Biomarkers of Common Eye Diseases |
https://ClinicalTrials.gov/show/NCT04101604 |
Recruiting |
Sun Yat-sen University |
2020-10-01 |
| NCT04067583 |
A Follow-up Physician Survey to Evaluate Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe |
https://ClinicalTrials.gov/show/NCT04067583 |
Recruiting |
Bayer |
2020-06-30 |
| NCT04032808 |
Evaluation of the Performance of Self-monitoring Optimized by Therapeutic Education in the Recurrence of Wet Age-related Macular Degeneration (AMD) |
https://ClinicalTrials.gov/show/NCT04032808 |
Recruiting |
Clinique Beau Soleil |
2021-07-10 |
| NCT03999801 |
Long-term Follow-Up Study of RGX-314 |
https://ClinicalTrials.gov/show/NCT03999801 |
Enrolling by invitation |
Regenxbio Inc. |
2024-06-30 |
| NCT03969303 |
NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients |
https://ClinicalTrials.gov/show/NCT03969303 |
Recruiting |
Notal Vision Ltd |
2019-10-20 |
| NCT03939195 |
OCTA (Optical Coherence Angiography Tomography) Versus Structural OCT(Optical Coherence Tomography) in Neovascular AMD (Age Macular Degeneration) |
https://ClinicalTrials.gov/show/NCT03939195 |
Recruiting |
Centre Hospitalier Intercommunal Creteil |
2019-07-31 |
| NCT03927430 |
Surgical Outcome of Macular Membrane Peeling Associated With Significant Macular Drusen |
https://ClinicalTrials.gov/show/NCT03927430 |
Completed |
Klinikum Chemnitz gGmbH |
2019-03-01 |
| NCT03838679 |
Imaging of the Angiofibrotic Switch in Neovascular AMD |
https://ClinicalTrials.gov/show/NCT03838679 |
Recruiting |
Medical University of Vienna |
2022-04-28 |
| NCT03803631 |
CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl) |
https://ClinicalTrials.gov/show/NCT03803631 |
Recruiting |
Centre Hospitalier Intercommunal Creteil |
2021-05-30 |
| NCT03744806 |
Blood-aqueous Barrier Integrity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular AMD |
https://ClinicalTrials.gov/show/NCT03744806 |
Completed |
Medical University of Lublin |
2015-09-30 |
| NCT03680326 |
Intravitreal Anti-vascular Endothelial Growth Factor Administration and Its Influence on Vitreomacular Interface- and Retinal Morphology in Eyes With Neovascular Age-related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT03680326 |
Completed |
Hospital Hietzing |
2018-03-22 |
| NCT03679156 |
Retinal Pigment Epithelial Characteristics in Eyes With Neovascular Age-related Macular Degeneration Following Long-term Treatment With Anti Neovascular Endothelial Growth Factor |
https://ClinicalTrials.gov/show/NCT03679156 |
Completed |
Hospital Hietzing |
2016-11-02 |
| NCT03614481 |
Clinical and Genetic Analyzes of Age-related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT03614481 |
Recruiting |
Centre Hospitalier Intercommunal Creteil |
2022-11-30 |
| NCT03521895 |
An Integrated Analysis of the Effectiveness of Intravitreal (IVT) Aflibercept (Eylea) in Routine Clinical Practice Based on Two Large Observational Studies |
https://ClinicalTrials.gov/show/NCT03521895 |
Completed |
Bayer |
2018-11-30 |
| NCT03504540 |
Comparison of Complement Factors and Genetic Polymorphisms of AMD Between Patients With Systemic Lupus Erythematosus (SLE) With and Without Retinal “Pseudo-drusen-like” Deposits: Case-control Study (PL-AMD) |
https://ClinicalTrials.gov/show/NCT03504540 |
Recruiting |
Fondation Ophtalmologique Adolphe de Rothschild |
2021-04-30 |
| NCT03476291 |
Research of Automated Maculopathy Screening Based on AI Techniques Using OCT Images |
https://ClinicalTrials.gov/show/NCT03476291 |
Active, not recruiting |
The First Affiliated Hospital with Nanjing Medical University |
2018-06-01 |
| NCT03438669 |
Correlation Between Visual Acuity Measurements, Quality of Life and Morphological Parameters in Wet AMD Patients |
https://ClinicalTrials.gov/show/NCT03438669 |
Completed |
Vista Klinik |
2017-05-30 |
| NCT03433885 |
Wenzhou Dry Age-related Macular Degeneration (AMD) Progression Study |
https://ClinicalTrials.gov/show/NCT03433885 |
Recruiting |
The Eye Hospital of Wenzhou Medical University |
2020-12-31 |
| NCT03415984 |
Prevalence of Age Related Macular Degeneration (ARMD) in Parkinson’s Patients and Assesment of the Role of L-DOPA |
https://ClinicalTrials.gov/show/NCT03415984 |
Completed |
Fondation Ophtalmologique Adolphe de Rothschild |
2019-01-15 |
| NCT03411941 |
Evaluate the Effectiveness of Intravitreal (IVT) Aflibercept Injection in Clinical Practice in naïve Patients With Neovascular Age-related Macular Degeneration (nAMD) |
https://ClinicalTrials.gov/show/NCT03411941 |
Completed |
Bayer |
2019-03-01 |
| NCT01256827 |
Seven Year Update of Macular Degeneration Patients |
https://ClinicalTrials.gov/show/NCT01256827 |
Completed |
University of California, San Francisco |
2012-10-31 |
| NCT01245387 |
Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT01245387 |
Completed |
Pfizer |
2009-12-31 |
| NCT01233128 |
Vascular Endothelial Growth Factor (VEGF) & LOC387715/HTRA1 Polymorphism in Polypoidal Choroidal Vasculopathy |
https://ClinicalTrials.gov/show/NCT01233128 |
Completed |
Kyungpook National University Hospital |
2012-01-31 |
| NCT01233115 |
LOC387715/HTRA1 and the Combined Photodynamic Therapy With Intravitreal Bevacizumab in Polypoidal Choroidal Vasculopathy |
https://ClinicalTrials.gov/show/NCT01233115 |
Completed |
Kyungpook National University Hospital |
2011-08-31 |
| NCT01204541 |
A Single-Center Pilot Study to Assess Macular Function |
https://ClinicalTrials.gov/show/NCT01204541 |
Completed |
ORA, Inc. |
2010-10-31 |
| NCT01115387 |
GARM II: A Study on the Genetics of Age-related Maculopathy |
https://ClinicalTrials.gov/show/NCT01115387 |
Active, not recruiting |
University of California, Los Angeles |
2016-02-29 |
| NCT01115231 |
Complement Factor H Haplotypes and Smoking in Age-related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT01115231 |
Completed |
VA Office of Research and Development |
2015-06-30 |
| NCT01083147 |
Age-Related Macular Degeneration (AMD) - Beta Study Telemedicine Assessment |
https://ClinicalTrials.gov/show/NCT01083147 |
Completed |
Notal Vision Ltd |
2010-03-31 |
| NCT01080898 |
Evaluation of Optical Coherence Tomography. |
https://ClinicalTrials.gov/show/NCT01080898 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2010-10-31 |
| NCT01073592 |
Comparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV) |
https://ClinicalTrials.gov/show/NCT01073592 |
Completed |
Notal Vision Ltd |
2013-01-31 |
| NCT01010997 |
Foresee Home for Monitoring Age Related Macular Degeneration (AMD) |
https://ClinicalTrials.gov/show/NCT01010997 |
Completed |
Notal Vision Ltd |
2012-01-31 |
| NCT00963339 |
Age-Related Macular Degeneration (AMD) - Usability Study |
https://ClinicalTrials.gov/show/NCT00963339 |
Completed |
Notal Vision Ltd |
2009-12-31 |
| NCT00927303 |
The Spectralis-Cirrus Study |
https://ClinicalTrials.gov/show/NCT00927303 |
Completed |
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery |
2009-12-31 |
| NCT00884637 |
Correlation Between Visual Field Defects on FORESEE HOME and on Optical Coherence Tomography in Choroidal Neovascularization Subjects |
https://ClinicalTrials.gov/show/NCT00884637 |
Completed |
Notal Vision Ltd |
2013-12-31 |
| NCT00873106 |
Retinal Thickness and Volume Estimates Given by Time Domain and Spectral Optical Coherence Tomography |
https://ClinicalTrials.gov/show/NCT00873106 |
Completed |
Glostrup University Hospital, Copenhagen |
2010-03-31 |
| NCT00858208 |
Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice. |
https://ClinicalTrials.gov/show/NCT00858208 |
Completed |
Pfizer |
2011-04-30 |
| NCT00845273 |
Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT00845273 |
Completed |
Pfizer |
2014-02-28 |
| NCT00831961 |
Antibiotic Resistant Patterns of Conjunctival and Nasophayngeal Flora After Repeated Exposure to Topical Antibiotics |
https://ClinicalTrials.gov/show/NCT00831961 |
Completed |
Vanderbilt University |
2009-11-30 |
| NCT03833830 |
Vessel Density in nAMD After Longterm Anti-VEGF Treatment Compared to Recently Started Anti-VEGF Treatment |
https://ClinicalTrials.gov/show/NCT03833830 |
Completed |
Vista Klinik |
2019-04-02 |
| NCT01933152 |
Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT01933152 |
Completed |
Bayer |
2013-04-30 |
| NCT03894020 |
To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD) |
https://ClinicalTrials.gov/show/NCT03894020 |
Recruiting |
Gyroscope Therapeutics |
2023-01-08 |
| NCT03290794 |
Structured Post-marketing Surveillance to Collect the Safety Data of Intravitreal Aflibercept Injection (IVT-AFL) in Patients of Wet Age-related Macular Degeneration During Real World Clinical Practice |
https://ClinicalTrials.gov/show/NCT03290794 |
Recruiting |
Bayer |
2020-12-31 |
| NCT00801541 |
Characterization of Early Markers of Choroidal Neovascularization |
https://ClinicalTrials.gov/show/NCT00801541 |
Completed |
Association for Innovation and Biomedical Research on Light and Image |
2008-12-31 |
| NCT02821247 |
Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in Greece |
https://ClinicalTrials.gov/show/NCT02821247 |
Completed |
Bayer |
2019-07-10 |
| NCT02521142 |
Non-invasive Optical Angiography in Age-related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT02521142 |
Recruiting |
Medical University of Vienna |
2020-12-31 |
| NCT02463344 |
Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD |
https://ClinicalTrials.gov/show/NCT02463344 |
Completed |
Astellas Pharma Inc |
2019-08-19 |
| NCT01352975 |
Study of Dark Adaptation in Age-Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT01352975 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT03760055 |
Assessment of Visual Function With a Portable Brain-computer Interface |
https://ClinicalTrials.gov/show/NCT03760055 |
Enrolling by invitation |
NGoggle |
2024-01-31 |
| NCT00791427 |
ERG/EOG Study in AMD Patients Treated With Ranibizumab |
https://ClinicalTrials.gov/show/NCT00791427 |
Completed |
Retina Center, Minnesota |
2011-09-30 |
| NCT00787319 |
Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT00787319 |
Completed |
Pfizer |
2012-06-30 |
| NCT00776451 |
Usability of the PreView PHP for Home Use in Intermediate AMD Patients |
https://ClinicalTrials.gov/show/NCT00776451 |
Completed |
Notal Vision Ltd |
2009-02-28 |
| NCT00759044 |
Validation of a New Methodology for Mapping the Human Blood-Retinal Barrier Function |
https://ClinicalTrials.gov/show/NCT00759044 |
Completed |
Association for Innovation and Biomedical Research on Light and Image |
2010-10-31 |
| NCT00748384 |
Usability of the Foresee Home in Intermediate Age Related Macular Degeneration (AMD) Patients |
https://ClinicalTrials.gov/show/NCT00748384 |
Completed |
Notal Vision Ltd |
2013-03-31 |
| NCT00734487 |
AREDS 2 Ancillary Spectral Domain Optical Coherence Tomography Study |
https://ClinicalTrials.gov/show/NCT00734487 |
Completed |
Duke University |
2015-08-31 |
| NCT00727753 |
VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD) |
https://ClinicalTrials.gov/show/NCT00727753 |
Completed |
University of Zurich |
2012-12-31 |
| NCT00692887 |
Correlation Between Visual Field Defects on Foresee Preferential Hyperacuity Perimeter(PHP) and on Optical Coherence Tomography (OCT) in Patients With Choroidal Neovascularization (CNV) |
https://ClinicalTrials.gov/show/NCT00692887 |
Completed |
Notal Vision Ltd |
2008-12-31 |
| NCT00668213 |
Antioxidant Systems and Age-Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT00668213 |
Completed |
Vanderbilt University |
2010-06-30 |
| NCT00656903 |
High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT00656903 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00647439 |
Genetics and Markers of Degenerative and Inflammatory Eye Diseases |
https://ClinicalTrials.gov/show/NCT00647439 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00605943 |
Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab |
https://ClinicalTrials.gov/show/NCT00605943 |
Completed |
National Institutes of Health Clinical Center (CC) |
2009-08-04 |
| NCT00604071 |
Sensitivity of the Home Macular Perimeter (HMP) |
https://ClinicalTrials.gov/show/NCT00604071 |
Completed |
Notal Vision Ltd |
2008-09-30 |
| NCT00603850 |
Testing the Effectiveness of the Interactive Tutorial of the Home Macular Perimeter (HMP) |
https://ClinicalTrials.gov/show/NCT00603850 |
Completed |
Notal Vision Ltd |
2008-04-30 |
| NCT00596388 |
Usage of the Home Macular Perimeter (HMP) |
https://ClinicalTrials.gov/show/NCT00596388 |
Completed |
Notal Vision Ltd |
2013-01-31 |
| NCT00595998 |
Sensitivity and Specificity of the Home Macular Perimeter (HMP) |
https://ClinicalTrials.gov/show/NCT00595998 |
Completed |
Notal Vision Ltd |
2008-09-30 |
| NCT00592826 |
HMP (Home Macular Perimeter) -Usability Trial |
https://ClinicalTrials.gov/show/NCT00592826 |
Completed |
Notal Vision Ltd |
2008-01-31 |
| NCT00559234 |
Potential Research Participants for Future Studies of Inherited Eye Diseases |
https://ClinicalTrials.gov/show/NCT00559234 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00556114 |
A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging |
https://ClinicalTrials.gov/show/NCT00556114 |
Completed |
University of California, Irvine |
2013-07-31 |
| NCT00549055 |
A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life. |
https://ClinicalTrials.gov/show/NCT00549055 |
Completed |
Pfizer |
2009-10-31 |
| NCT00531141 |
The Optical Coherence Tomography in Age-Related Macular Degeneration Study: The OCT in AMD Study |
https://ClinicalTrials.gov/show/NCT00531141 |
Completed |
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery |
2008-06-30 |
| NCT00494325 |
The Role of Macular Pigment in Patients With Age-related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT00494325 |
Completed |
University Hospital Inselspital, Berne |
2010-12-31 |
| NCT00465400 |
Oxidative Stress in Patients With Age-Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT00465400 |
Completed |
University Hospital, Basel, Switzerland |
2007-12-31 |
| NCT00460408 |
Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT00460408 |
Completed |
Pfizer |
2012-02-29 |
| NCT00417846 |
Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study) |
https://ClinicalTrials.gov/show/NCT00417846 |
Completed |
Johns Hopkins University |
2009-08-31 |
| NCT00393692 |
Fundus Autofluorescence Imaging in Age-related Macular Degeneration Using Confocal Scanning Laser Ophthalmoscopy |
https://ClinicalTrials.gov/show/NCT00393692 |
Completed |
University Hospital, Bonn |
2016-04-30 |
| NCT00359008 |
PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV) |
https://ClinicalTrials.gov/show/NCT00359008 |
Completed |
Notal Vision Ltd |
NA |
| NCT00358345 |
PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization |
https://ClinicalTrials.gov/show/NCT00358345 |
Completed |
Notal Vision Ltd |
NA |
| NCT00357578 |
Genetic Study of Age-Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT00357578 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00343603 |
Tracking Optical Coherence Tomography |
https://ClinicalTrials.gov/show/NCT00343603 |
Completed |
University of Pittsburgh |
2010-12-31 |
| NCT00342251 |
Investigating Age-Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT00342251 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00277784 |
High-Resolution Ultrasound Imaging of the Retina and Choroid for Detection on Age Related Macular Degeneration |
https://ClinicalTrials.gov/show/NCT00277784 |
Completed |
Weill Medical College of Cornell University |
2006-06-30 |
| NCT00797524 |
Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherence Tomography |
https://ClinicalTrials.gov/show/NCT00797524 |
Completed |
Association for Innovation and Biomedical Research on Light and Image |
2010-10-31 |
| NCT00001395 |
Long Term Follow-Up of Diabetic Retinopathy |
https://ClinicalTrials.gov/show/NCT00001395 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001346 |
Diabetic Retinopathy and Visual Function Study |
https://ClinicalTrials.gov/show/NCT00001346 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00041444 |
Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye Study |
https://ClinicalTrials.gov/show/NCT00041444 |
Completed |
University of Wisconsin, Madison |
2006-11-30 |
| NCT00001733 |
Screening for Studies on Retinovascular Diseases |
https://ClinicalTrials.gov/show/NCT00001733 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |